Compound pharmaceutical composition containing piperacillin sodium and tazobactam sodium and preparation method of compound pharmaceutical composition

A technology of tazobactam sodium and piperacillin sodium, which is applied in the directions of drug delivery, active ingredients of heterocyclic compounds, and medical preparations of non-active ingredients, etc., can solve the problem of large number of impurities, high substance content, poor stability, etc. The problem is to overcome the complex formula, simple preparation process and small fluctuation range.

Active Publication Date: 2016-04-06
FUAN PHARM (GRP) CO LTD +1
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the piperacillin sodium-tazobactam sodium compound preparation for injection on the domestic market is prepared by directly packing the aseptic powder of piperacillin sodium and tazobactam sodium according to the weight ratio of 4:1, and its disadvantage is that Poor stability, high content of related substances
[0004] Chinese patent application CN101632670A discloses a piperacillin sodium tazobactam suspension powder injection, which is made into a powder injection by freeze-drying using emulsification suspension technology, and its components include: 4-8 parts of piperacillin sodium, tazobactam 1 part of bactam sodium, 10-30 parts of emulsifier, 3-20 parts of co-emulsifier, 5-40 parts of freeze-dried

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound pharmaceutical composition containing piperacillin sodium and tazobactam sodium and preparation method of compound pharmaceutical composition
  • Compound pharmaceutical composition containing piperacillin sodium and tazobactam sodium and preparation method of compound pharmaceutical composition
  • Compound pharmaceutical composition containing piperacillin sodium and tazobactam sodium and preparation method of compound pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Prescription Screening of Piperacillin Sodium and Tazobactam Sodium

[0037] Taking the dissolution time as an index and using water for injection as a solvent, the preliminary selection of the prescription was carried out. The results of the investigation are shown in Table 1:

[0038]

[0039]

[0040] The results showed that when the dissolution time was taken as an index, the pH value was adjusted with citric acid-sodium citrate buffer solution in the formula of piperacillin sodium+tazobactam sodium+mannitol+lactose (4:1:2:1), The dissolution time is the shortest.

Embodiment 2

[0042] Prescription 1.25g, 1000 bottles

[0043]

[0044] Dissolve the prescribed amount of piperacillin sodium, tazobactam sodium, mannitol, and lactose in 1600ml of water for injection. After the dissolution is complete, adjust the pH value to 6.0-6.4 with citric acid-sodium citrate, and add 400ml of Add water for injection, add activated carbon for needles to absorb the heat source, sterilize and filter with membrane filters with 0.45 μm and 0.22 μm pore size respectively, put the sterile solution into bottles, and freeze-dry it.

Embodiment 3

[0050] Prescription 2.5g, 1000 bottles

[0051]

[0052] Dissolve the prescribed amount of piperacillin sodium, tazobactam sodium, mannitol, and lactose in 3200ml of water for injection. After the dissolution is complete, adjust the pH value to 5.8-6.2 with citric acid-sodium citrate, and add 800ml of Add water for injection, add activated carbon for needles to absorb the heat source, sterilize and filter with membrane filters with 0.45 μm and 0.22 μm pore size respectively, put the sterile solution into bottles, and freeze-dry it.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a compound pharmaceutical composition containing piperacillin sodium and tazobactam sodium. The compound pharmaceutical composition contains piperacillin sodium, tazobactam sodium, an excipient and a pH regulator, wherein the ratio of piperacillin sodium to tazobactam sodium is 4:1. Moreover, the invention also discloses a preparation method of the pharmaceutical composition. Compared with the prior art, the pharmaceutical composition disclosed by the invention not only is good in stability, low in impurity content and high in safety, but also is improved in dissolution rate and is more suitable for industrialization.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a compound pharmaceutical composition of piperacillin sodium and tazobactam sodium. Background technique [0002] Piperacillin Sodium and Tazobactam Sodium is a compound antibiotic developed by Dapeng Pharmaceutical Co., Ltd. of Japan. It has two ratios of 8:1 and 4:1. The ratio of 8:1 was first introduced in France in 1992. The 4:1 ratio was first listed in Japan in 2001. In the compound preparation, piperacillin sodium is a broad-spectrum semi-synthetic penicillin antibiotic, and tazobactam sodium is a β-lactamase inhibitor. When the two are used in combination, they can produce obvious synergistic effects. They are mainly used clinically. In the treatment of sepsis, pneumonia, pyelonephritis and complicated cystitis. [0003] At present, the piperacillin sodium-tazobactam sodium compound preparation for injection on the domestic market is prep...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/496A61K9/19A61K47/26A61P31/04A61K31/431
CPCA61K9/0019A61K9/19A61K31/431A61K31/496A61K47/26A61K2300/00
Inventor 蒋晨
Owner FUAN PHARM (GRP) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap